Evidence map›Paper›PMID 31569435›Full record

ArticleNutrients2019

New Evaluation of Isoflavone Exposure in the French Population.

Alexandre Lee, Laetitia Beaubernard, Valérie Lamothe, Catherine Bennetau-Pelissero

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Alexandre LeeBordeaux Sciences Agro, F-33175 Gradignan, France. alexandre.lee@agro-bordeaux.fr.
Laetitia BeaubernardBordeaux Sciences Agro, F-33175 Gradignan, France. l.beaubernard@gmail.com.
Valérie LamotheBordeaux Sciences Agro, F-33175 Gradignan, France. valerie.lamothe@agro-bordeaux.fr.
Catherine Bennetau-PelisseroBordeaux Sciences Agro, F-33175 Gradignan, France. catherine.bennetau@u-bordeaux.fr.
École Nationale Supérieure des Sciences Agronomiques de Bordeaux-Aquitaine · FRUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study relates the present evaluation of exposure to estrogenic isoflavones of French consumers through two approaches: (1) identification of the isoflavone sources in the French food offering, (2) a consumption-survey on premenopausal women. For the foodstuff approach 150 food-items were analysed for genistein and daidzein. Additionally, 12,707 labels of processed-foods from French supermarket websites and a restaurant-supplier website were screened, and 1616 foodstuffs of interest were retained. The sources of phytoestrogens considered were soy, pea, broad bean and lupine. A price analysis was performed. A total of 270 premenopausal women from the French metropolitan territory were interviewed for their global diet habits and soy consumption and perception. In supermarkets, there were significantly less selected foodstuffs containing soy than in restaurant (11.76% vs. 25.71%,

Indexed as

AdultCommerceConsumer BehaviorDietDiet SurveysFeeding BehaviorFemaleFood SupplyFranceGenisteinHumansIsoflavonesPhytoestrogensPremenopauseSoy FoodsSurveys and QuestionnairesdaidzeinGenisteinIsoflavonesPhytoestrogensendocrine disruptorsexposurefoodstuff labellinghealthisoflavoneslegumesphytoestrogenspremenopausal women

Identifiers

PMID31569435
PMCPMC6835759
OpenAlexW2976704871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.